Open AccessRisk Factors for Complicated Community-Acquired Pneumonia Course in Patients Treated with β-Lactam Monotherapy
Author(s) -
Giedrė Cincilevičiūtė,
Vaida Averjanovaitė,
Rūta Mereškevičienė,
Gabrielė Pliatkienė,
Rolandas Zablockis,
Edvardas Danila
Publication year - 2021
Publication title -
advances in respiratory medicine
Language(s) - English
Resource type - Journals
eISSN - 2543-6031
pISSN - 2451-4934
DOI - 10.5603/arm.a2021.0070
Subject(s) - medicine , community acquired pneumonia , pneumonia , intensive care medicine
We aimed to investigate community-acquired pneumonia (CAP) requiring hospitalisation, empirically treated with b-lactam monotherapy, with 30-day mortality and risk factors predicting its complicated course.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom